Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola disease, an early-onset recessive form of dementia preceded by bone cysts and fractures. The same type of mutations has recently been shown to cause frontotemporal dementia (FTD) without the presence of any bone phenotype. Here, we further confirm the association of TREM2 mutations with FTD-like phenotypes by reporting the first compound heterozygous mutation in a Turkish family. (C) 2013 The Authors. Published by Elsevier Inc. All rights reserved
Genetic variants in the triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to...
Rare coding variants in the triggering receptor expressed on myeloid cells‐2 (TREM2) gene have been ...
Background: A rare variant in the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) gene has ...
Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola dise...
AbstractTriggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hak...
TREM2 mutations were first identified in Nasu-Hakola disease, a rare autosomal recessive disease cha...
Homozygous mutations in exon 2 of TREM2, a gene involved in Nasu-Hakola disease, can cause frontotem...
Frontotemporal dementia (FTD) is clinically characterized by behavioral changes, language impairment...
Triggering Receptor Expressed on Myeloid cells (TREM)2 deficiency originates a genetic syndrome char...
The differential diagnosis of young-onset progressive dementia is an issue that requires effort. Rec...
A causative association was recently demonstrated between homozygous TREM2 mutations and frontotempo...
Homozygous mutations in TREM2 have been recently identified by exome sequencing in families presenti...
Frontotemporal dementia (FTD) is a clinically and genetically heterogeneous disorder. Rare TREM2 var...
Recent evidence suggests that rare genetic variants within the TREM2 gene are associated with increa...
Nasu-Hakola disease is a rare, recessively inherited disease characterized by presenile dementia and...
Genetic variants in the triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to...
Rare coding variants in the triggering receptor expressed on myeloid cells‐2 (TREM2) gene have been ...
Background: A rare variant in the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) gene has ...
Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola dise...
AbstractTriggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hak...
TREM2 mutations were first identified in Nasu-Hakola disease, a rare autosomal recessive disease cha...
Homozygous mutations in exon 2 of TREM2, a gene involved in Nasu-Hakola disease, can cause frontotem...
Frontotemporal dementia (FTD) is clinically characterized by behavioral changes, language impairment...
Triggering Receptor Expressed on Myeloid cells (TREM)2 deficiency originates a genetic syndrome char...
The differential diagnosis of young-onset progressive dementia is an issue that requires effort. Rec...
A causative association was recently demonstrated between homozygous TREM2 mutations and frontotempo...
Homozygous mutations in TREM2 have been recently identified by exome sequencing in families presenti...
Frontotemporal dementia (FTD) is a clinically and genetically heterogeneous disorder. Rare TREM2 var...
Recent evidence suggests that rare genetic variants within the TREM2 gene are associated with increa...
Nasu-Hakola disease is a rare, recessively inherited disease characterized by presenile dementia and...
Genetic variants in the triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to...
Rare coding variants in the triggering receptor expressed on myeloid cells‐2 (TREM2) gene have been ...
Background: A rare variant in the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) gene has ...